References
- Bai, A.P. and Ouyang, Q. (2006) Probiotics and inflammatory bowel diseases. Postgrad. Med. J., 82, 376-382. https://doi.org/10.1136/pgmj.2005.040899
- Stein, J., Hartmann, F. and Dignass, A.U. (2010) Diagnosis and management of iron deficiency anemia in patients with IBD. Nat. Rev. Gastroenterol. Hepatol., 7, 599-610. https://doi.org/10.1038/nrgastro.2010.151
- Kaser, A., Zeissig, S. and Blumberg, R.S. (2010) Inflammatory bowel disease. Annu. Rev. Immunol., 28, 573-621. https://doi.org/10.1146/annurev-immunol-030409-101225
- Rogler, G. and Andus, T. (1998) Cytokines in inflammatory bowel disease. World J. Surg., 22, 382-389. https://doi.org/10.1007/s002689900401
- Atreya, R., Mudter, J., Finotto, S., Mullberg, J., Jostock, T., Wirtz, S., Schutz, M., Bartsch, B., Holtmann, M., Becker, C., Strand, D., Czaja, J., Schlaak, J.F., Lehr, H.A., Autschbach, F., Schurmann, G., Nishimoto, N., Yoshizaki, K., Ito, H., Kishimoto, T., Galle, P.R., Rose-John, S. and Neurath, M.F. (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat. Med., 6, 583-588. https://doi.org/10.1038/75068
- Shen, D., Liu, C., Xu, R. and Zhang, F. (2012) Human gut microbiota: dysbiosis and manipulation. Front. Cell. Infect. Microbiol., 2, 123.
- de Vos, W.M. and de Vos, E.A. (2012) Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr. Rev., 70 Suppl 1, S45-56. https://doi.org/10.1111/j.1753-4887.2012.00505.x
- Abraham, C. and Medzhitov, R. (2011) Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology, 140, 1729-1737. https://doi.org/10.1053/j.gastro.2011.02.012
- Bien, J., Palagani, V. and Bozko, P. (2013) The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? Ther. Adv. Gastroenterol., 6, 53-68. https://doi.org/10.1177/1756283X12454590
- Walker, A.W. and Lawley, T.D. (2013) Therapeutic modulation of intestinal dysbiosis. Pharmacol. Res., 69, 75-86. https://doi.org/10.1016/j.phrs.2012.09.008
- Uccello, M., Malaguarnera, G., Basile, F., D'Agata, V., Malaguarnera, M., Bertino, G., Vacante, M., Drago, F. and Biondi, A. (2012) Potential role of probiotics on colorectal cancer prevention. BMC Surg., 12 Suppl 1, S35. https://doi.org/10.1186/1471-2482-12-S1-S35
- Ouwehand, A.C., Salminen, S. and Isolauri, E. (2002) Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek, 82, 279-289. https://doi.org/10.1023/A:1020620607611
- Salminen, S., Bouley, C., Boutron-Ruault, M.C., Cummings, J.H., Franck, A., Gibson, G.R., Isolauri, E., Moreau, M.C., Roberfroid, M. and Rowland, I. (1998) Functional food science and gastrointestinal physiology and function. Br. J. Nutr., 80 Suppl 1, S147-171. https://doi.org/10.1079/BJN19980108
- Sang, L.X., Chang, B., Zhang, W.L., Wu, X.M., Li, X.H. and Jiang, M. (2010) Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis. World J. Gastroenterol., 16, 1908-1915. https://doi.org/10.3748/wjg.v16.i15.1908
- Lee, J.S., Chung, M.J. and Seo, J.G. (2013) In Vitro Evaluation of Antimicrobial Activity of Lactic Acid Bacteria against Clostridium difficile. Toxicol. Res., 29, 99-106. https://doi.org/10.5487/TR.2013.29.2.099
- Miyauchi, E., Ogita, T., Miyamoto, J., Kawamoto, S., Morita, H., Ohno, H., Suzuki, T. and Tanabe, S. (2013) Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: involvement of intestinal epithelial costimulatory molecules. PLoS One, 8, e79735. https://doi.org/10.1371/journal.pone.0079735
- Matsumoto, Y. (2005) New approach to immunotherapy against organ-specific autoimmune diseases with T cell receptor and chemokine receptor DNA vaccines. Curr. Drug Targets Immune Endocr. Metab. Disord., 5, 73-77. https://doi.org/10.2174/1568008053174732
- Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., Wang, G. and Xia, B. (2014) Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrateproducing bacteria in inflammatory bowel disease. J. Clin. Microbiol., 52, 398-406. https://doi.org/10.1128/JCM.01500-13
- MacPherson, B.R. and Pfeiffer, C.J. (1978) Experimental production of diffuse colitis in rats. Digestion, 17, 135-150. https://doi.org/10.1159/000198104
- Strober, W., Fuss, I.J. and Blumberg, R.S. (2002) The immunology of mucosal models of inflammation. Annu. Rev. Immunol., 20, 495-549. https://doi.org/10.1146/annurev.immunol.20.100301.064816
- Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y. and Nakaya, R. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology, 98, 694-702.
- Hyun, E., Andrade-Gordon, P., Steinhoff, M. and Vergnolle, N. (2008) Protease-activated receptor-2 activation: a major actor in intestinal inflammation. Gut, 57, 1222-1229. https://doi.org/10.1136/gut.2008.150722
- Baumgart, D.C. and Sandborn, W.J. (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet, 369, 1641-1657. https://doi.org/10.1016/S0140-6736(07)60751-X
- Cooper, H.S., Murthy, S.N., Shah, R.S. and Sedergran, D.J. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest., 69, 238-249.
- Hedger, M.P. and Meinhardt, A. (2003) Cytokines and the immune-testicular axis. J. Reprod. Immunol., 58, 1-26. https://doi.org/10.1016/S0165-0378(02)00060-8
- Eming, S.A., Kaufmann, J., Lohrer, R. and Krieg, T. (2007) [Chronic wounds. Novel approaches in research and therapy]. Hautarzt, 58, 939-944. https://doi.org/10.1007/s00105-007-1402-1
- Guha, M., O'Connell, M.A., Pawlinski, R., Hollis, A., McGovern, P., Yan, S.F., Stern, D. and Mackman, N. (2001) Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood, 98, 1429-1439. https://doi.org/10.1182/blood.V98.5.1429
- D'Aiuto, F., Parkar, M., Brett, P.M., Ready, D. and Tonetti, M.S. (2004) Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine, 28, 29-34. https://doi.org/10.1016/j.cyto.2004.06.005
- Cronstein, B.N. and Terkeltaub, R. (2006) Interleukin-6 and chronic inflammation. Arthritis Res. Ther., 8 Suppl 1, S3.
- Dieleman, L. and Hoentjen, F. (2012) [Probiotics have a limited role in the treatment of inflammatory bowel disease]. Ned. Tijdschr. Geneeskd., 156, A5206.
Cited by
- Grape seed extract improves epithelial structure and suppresses inflammation in ileum of IL-10-deficient mice vol.5, pp.10, 2014, https://doi.org/10.1039/C4FO00451E
- A 15-amino acid C-terminal peptide of beta-defensin-3 inhibits bone resorption by inhibiting the osteoclast differentiation and disrupting podosome belt formation vol.95, pp.12, 2017, https://doi.org/10.1007/s00109-017-1589-2
- Amelioration of obesity-related characteristics by a probiotic formulation in a high-fat diet-induced obese rat model pp.1436-6215, 2017, https://doi.org/10.1007/s00394-017-1481-4
- Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases vol.16, pp.9, 2015, https://doi.org/10.3390/ijms160920841
- Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies vol.30, pp.1, 2017, https://doi.org/10.1128/CMR.00049-16
- The Probiotic, ID-JPL934, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice Through Inhibition of Proinflammatory Cytokines Expression vol.21, pp.9, 2018, https://doi.org/10.1089/jmf.2017.4152